Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
02/2004
02/05/2004WO2004011141A1 Size-exclusion ion-exchange particles
02/05/2004WO2004011079A2 Method of treating disorders by altering ion flux across cell membranes with electric fields
02/05/2004WO2004011025A1 Plant cell wall loosening activity of group 2/3 allergens of grass pollen
02/05/2004WO2004010927A2 Method for increasing insulin sensitivity and for treating and preventing type 2 diabetes
02/05/2004WO2004010850A2 Method for identifying cancer risk
02/05/2004WO2004010848A2 Oncogenes useful for the identification of urinary bladder cancer
02/05/2004WO2003100541A3 Methods for profiling molecules with an objective function
02/05/2004WO2003099228A8 Compositions and processes for inhibiting gene expression using polynucleotides
02/05/2004WO2003097871A3 Marker molecules associated with lung tumors
02/05/2004WO2003097870A3 Method for detection of somatic mutations
02/05/2004WO2003097789A3 Farnesyl diphosphate synthase from pseudomonas aeruginosa
02/05/2004WO2003096971A3 Diagnosis of glaucoma
02/05/2004WO2003093502A3 Multiplexed determination of nucleic acid polymorphisms
02/05/2004WO2003093501A3 Ssh based methods for identifying and isolating unique nucleic acid sequences
02/05/2004WO2003093494A3 Apparatus including ion transport detecting structures and methods of use
02/05/2004WO2003091692A3 Methods for evaluation of in vitro aminoacyl trna production using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry
02/05/2004WO2003089670A3 Reagents for monitoring nuclei acid amplification and methods of using same
02/05/2004WO2003089624A3 Fc receptor homolog, reagents, and uses thereof
02/05/2004WO2003087829A3 Human papilloma virus detection with dna microarray
02/05/2004WO2003087818A3 Diagnostic and therapeutic use of kremen 1 and 2, inhibitors of the canonical wnt-signaltransduction
02/05/2004WO2003087353A3 Purified polypeptides involved in membrane biogenesis
02/05/2004WO2003086461A3 Use of substances for treating tumors
02/05/2004WO2003085086A9 Motif-grafted hybrid polypeptides and uses thereof
02/05/2004WO2003084989A3 La1 - the genome of a lactobacillus strain
02/05/2004WO2003083442A3 Life sciences business systems and methods
02/05/2004WO2003083038A3 Disruption of the redk gene
02/05/2004WO2003082255A3 Use of mob-5 in pain
02/05/2004WO2003081234A3 Diagnostics and therapeutics for diseases associated with homo sapiens g - protein - coupled receptor 8 (gpr8)
02/05/2004WO2003081204A3 Microscale sensor element and related device and method of manufacture
02/05/2004WO2003080871A3 Method for detection and differentiation of mycobacterium tuberculosis complex
02/05/2004WO2003076653A3 Dna conformational switches as sensitive electronic sensors of analytes
02/05/2004WO2003076651A3 Cancer associated araf1 protein kinase and its uses
02/05/2004WO2003072811A3 The use of ribozymes in the detection of adventitious agents
02/05/2004WO2003071865A3 Molecular markers for identification of fat and lean phenotypes in chickens
02/05/2004WO2003069341A3 Method of diagnosis of inflammatory diseases using calgranulin c
02/05/2004WO2003066878A3 Nucleic acid analysis using layered expression scanning
02/05/2004WO2003066817A3 Compositions and methods for rolling circle amplification
02/05/2004WO2003064593A3 Antigen panels and methods of using the same
02/05/2004WO2003062264A3 Functional ligand display
02/05/2004WO2003059944A3 Gb virus b based replicons and replicon enhanced cells
02/05/2004WO2003057204A3 Modulation of iamt (pimt or pcmt) in immune system
02/05/2004WO2003055911A8 Cystine-knot fold protein
02/05/2004WO2003054139B1 Compositions and methods utilizing dna polymerases
02/05/2004WO2003046512A3 Method for amplification of molecular bio-assay signals
02/05/2004WO2003042397A3 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby
02/05/2004WO2003024386A3 Use of potent, selective and non toxic c-kit inhibitors for treating interstitial cystitis
02/05/2004WO2003020947A3 Mid 9002, a human sulfatase family member and uses therefor
02/05/2004WO2003016915A8 Tumor specific oligosaccharide sequences and use thereof
02/05/2004WO2002098355A3 Methods and reagents for diagnosis and treatment of insulin resistance and related conditions
02/05/2004WO2002074991A3 Detection of microorganisms using inducible genes
02/05/2004WO2002072776A3 Cell culture system for synthesis of infectious hepatitis c virus
02/05/2004WO2002061046A3 Novel nucleic acid and polypeptide molecules
02/05/2004WO2002059373A3 Genes overexpressed in prostate disorders as diagnostic and therapeutic targets
02/05/2004WO2002018632A3 Method for determining the degree of methylation of defined cytosines in genomic dna in the sequence context 5'-cpg-3'
02/05/2004US20040025199 Comprises g-protein couple receptors for identifying modulators of g-protein activity and diagnosis and treatment of infections, nervous system, tumor, autoimmune and inflammatory disorders
02/05/2004US20040025196 Comprises nucleotide sequences coding proteins with plenty of SH3 domains (POSH) for preventing viral and bacterial infection and replication; rational drug design; viricides; antiapoptosis agents; bactericides
02/05/2004US20040025194 Beta chain-associated regulator of apoptosis
02/05/2004US20040024537 Hybridization affinity information for the sample polymers such as nucleic acid sequences, is clustered so that the differences, if any, between or among the sample polymers can be readily identified
02/05/2004US20040024536 Determination of optimal local sequence alignment similarity score
02/05/2004US20040024193 Method of detecting and quantifying hepatitis C virus
02/05/2004US20040024192 19 human secreted proteins
02/05/2004US20040024068 Antimicrobial compounds
02/05/2004US20040024064 Determining risk for developing a fat metabolism disorder by comparing a sample Gs alpha expression level with that of the normal level; treating the disorder with a nucleic acid that codes a Gs alpha protein; prognosis; diagnosis;
02/05/2004US20040023907 Infection model
02/05/2004US20040023866 Isolated Bcl-2 domain-containing polypeptides from Mycobacterial species, including M. tuberculosis, M. avium, M. bovis, M. leprae and M. smegmatis, and from Streptomyces species, including S. coelicolor, as well as modifications of
02/05/2004US20040023862 Newly identified uses of BRS3 polypeptides and polynucleotides encoding such polypeptides, to their use in therapy of ischemia, of neurodegenerative diseases, of memory and attention disorders, and in identifying compounds which may be
02/05/2004US20040023856 Purified DNA comprising a sequence encoding a B1k chain of laminin. Vector comprising a DNA sequence encoding a B1k protein.
02/05/2004US20040023854 Adiponectin and uses thereof
02/05/2004US20040023400 Test piece for assaying high density lipoprotein (hdl) cholesterol
02/05/2004US20040023392 Use in introducing predetermined change at predetermined location in target gene in living cell; oligodeoxynucleotide is modified by attachment of 3' and 5' blocking substituents such as a 3'-3'linked cytosine nucleotide and a 5' linked dye
02/05/2004US20040023391 Using surface-mediated protein transfected cell microarrays to screen polypeptide and enzyme activities; high throughput assay; drug screening
02/05/2004US20040023369 Apparatus comprising immobilized hydrolase which utilizes colorimetric and calorimetric analysis for monitoring and detecting toxic, hazardous and nerve blocking agents
02/05/2004US20040023368 Apparatus for light controlled parallel synthesis of molecular sequence arrays on solid surfaces
02/05/2004US20040023343 Biosynthetic genes for spinosyn insecticide production
02/05/2004US20040023337 IL-13 mutein proteins, antibodies, compositions, methods and uses
02/05/2004US20040023335 IL-17 like molecules and uses thereof
02/05/2004US20040023327 Using site directed mutagenesis to cause nucleotide sequences alterations in target protein; polypeptide engineering
02/05/2004US20040023326 Comprises inhibitory monoclonal antibody for controlling metabolic processes associated with cytochrome c oxidase/debrisoquine hydroxylase; drug screening and development; competetive binding
02/05/2004US20040023319 Using colorimetric and flow cytometric analysis to monitor staining pattern of permeant and impermeant dyes in order to detect bacterial and/or fungal spores which are capable of germination
02/05/2004US20040023318 Method of isolating stem cells
02/05/2004US20040023317 Implantable biosensor from stratified nanostructured membranes
02/05/2004US20040023315 Transgenic yeast cells coding membrane receptor proteins for diagnosis and treatment of pancreatitis, pancreatic cancer, gastrointestinal disorders and irritable bowel disease
02/05/2004US20040023312 Based on identification of abnormal behaviour of adenosine A2A receptor, both as regards bond to specific ligands and coupling to adenylate cyclase system characteristic of cells genetically predisposed to develop Huntington's Disease
02/05/2004US20040023311 Modulation of angiogenesis through targeting of cysteine oxygenase activity
02/05/2004US20040023307 DNA encoding a novel RG1 polypeptide
02/05/2004US20040023306 Methods for quantitative proteome analysis of glycoproteins
02/05/2004US20040023305 Comprises single stranded nucleic acid probe and/or monoclonal antibody for detection of streptococcal infections, as well as, treatment for respiratory system disorders; immunoassays
02/05/2004US20040023298 Identifying modulators of jun n-terminal and/or stress activated protein kinase (JNK/SAPKs) activities for diagnosis and treatment of cancer
02/05/2004US20040023293 Biochips for characterizing biological processes
02/05/2004US20040023290 Novel therapeutic agents that modulate enzymatic processes
02/05/2004US20040023288 Using tumor molecular markers, such as, cyclin dependent kinase, tumor suppressor protein expression to identifying cell proliferative disorders
02/05/2004US20040023286 Identifying modulators of chemoattractant receptor using reversed-activation of migration (RAM) high throughput assay
02/05/2004US20040023283 Comprises nucleotide sequences coding polypeptide for diagnosis, prevention and treatment of immunological, hematopoietic and inflammatory disorders
02/05/2004US20040023282 Obtaining chromosomal DNA from plants for preparing expression vectors comprising artificial chromosomes
02/05/2004US20040023280 Using presence of mutation in gene coding bone morphogenic protein receptor-2 protein (BMPR-II) to diagnose hereditary lung disorders
02/05/2004US20040023279 Method for quantitative determination of the degree of methylation of cytosines in CpG positions
02/05/2004US20040023278 Sialoadhesin family member-2 (SAF-2)
02/05/2004US20040023277 Using trinucleotide sequence duplication (CAG) present in gene coding calcium channel protein to diagnose nervous system and psychological disoders
02/05/2004US20040023276 LXR-ligand induced genes and proteins
02/05/2004US20040023275 Methods for genomic analysis